VRTX  valuation analysis

Basics
Name: Vertex Pharmaceuticals Incorporated
Description: Vertex Pharmaceuticals Incorporated engages in developing and commercializing therapies for treating cystic fibrosis. (more)
Industry: Biotechnology
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Nov 02, 2021
Market cap: $57.85B (141st)
Sales(TTM): $7.13B (386th)
Earnings(TTM): $2.18B (165th)

Value
FFER: 0.86 (why)
Actual price: $222.77
FFEThis is Vertex Pharmaceuticals Incorporated's the estimated price. FFEs are the denominator of the FFER ratio.: $260.51
Quantile: VRTX is priced correctly given its fundamentals.
Prices as of EOD 2021-12-22
Price & Estimates
Sales & Earnings history (TTM)
Notable
No notables found through heuristics.
Earnings / MarketCap
Vertex Pharmaceuticals Incorporated
"Biotechnology" industry
Sales / MarketCap
Vertex Pharmaceuticals Incorporated
"Biotechnology" industry
Book / MarketCap
Vertex Pharmaceuticals Incorporated
"Biotechnology" industry
Equity / Assets
Vertex Pharmaceuticals Incorporated
"Biotechnology" industry